Sex development, whereby the initially undifferentiated gonad is evolving to a testicular or ovarian fate, is undoubtedly one of the most intriguing processes of early embryonic life. Given the complexity of these processes, it is not surprising that they are prone to errors, leading to so-called Disorders of Sex Development (DSD) (1) . With a prevalence of around one in 2000-4500 births, they are among the most common birth defects (2) . In recent years, we have come to a better understanding of the molecular pathways involved in these complex processes and with the advent of next-generation sequencing technologies new genes and mechanisms have been identified (3) . Nevertheless, diagnostic approaches using targeted resequencing of DSD gene panels and whole-exome sequencing leave a majority of cases unsolved (4) . Genetic studies in DSD have mainly been oriented towards the coding portion of the genome. As many of the genes involved in sex development encode transcription factors (such as SRY, SOX9, NR5A1, FOXL2) requiring a rigorously regulated spatiotemporal expression, it can be expected that part of the unsolved cases are caused by a disturbed transcriptional or translational regulation of known or yet to be discovered DSD genes, resulting from non-coding genetic defects. Indeed, studies of developmental conditions such as DSD have uncovered a wide variety of non-coding mutations that affect regulatory elements and that result in reduced, mis-or overexpression of their target genes. Structural variations such as translocations, deletions, duplications or inversions can alter the normal chromatin conformation and can reposition enhancer elements which can lead to misexpression of their target gene. Such defects have been shown to be important in the pathogenesis of developmental conditions in general (5) (6) (7) . Here, we review regulatory defects that are known to be implicated in DSD, both in human as well as in other mammalian model organisms.
Regulatory defects in DSD

SRY
Two decades ago several individuals were described who had regulatory defects in Sex determining region Y (SRY) associated with 46,XY DSD; however for none of them the exact working mechanism could be elucidated (8) (9) (10) (11) . Concomitantly, comparative sequence analysis revealed highly conserved motifs surrounding SRY, suggesting a function in transcriptional regulation (12, 13) . The first irrefutable evidence for the importance of correct SRY regulation in humans was provided by Assumpção et al. who identified a three basepair (bp) deletion located in the SRY promoter in a patient with 46,XY complete gonadal dysgenesis and the father, who had undergone several reconstructive surgeries for severe hypospadias in childhood. This deletion partially removes a Sp1 binding site from the SRY promoter. Previous research had showed that Sp1 is one of the transcription factors (together with NR5A1 and WT1) necessary for transcriptional activation of SRY (14) . In 2008, a more extensive phylogenetic footprinting study showed four large conserved regions based on multiple sequence alignments. Two of the previously identified SRY regulatory defects (8, 11, 12) proved to be located within one of these regions, supporting their association with gonadal dysgenesis. Intriguingly, it was noticed that mouse 5
′ sequences, as well as Sry coding sequences were different from those of other species, suggesting different regulatory mechanisms. This is reflected by a unique murine expression pattern of Sry (15) .
SOX9
The most extensively studied regulatory region involved in DSD is undoubtedly the SRY-box 9 (SOX9) region. Loss-of-function coding mutations and regulatory defects including translocations, deletions and inversions can cause campomelic dysplasia (CD), a semi-lethal skeletal malformation syndrome with 46,XY DSD in 75% of male cases, while both coding and regulatory duplications are associated with 46,XX testicular DSD (called RevSex) (16, 17) . In addition, disruptions of specific long-range cis-regulatory elements are a known cause of Pierre Robin sequence (PRS), leading to craniofacial anomalies (18, 19) . The situation is even more complex: SOX9 regulatory duplications that overlap with RevSex duplications but extend to the neighbouring KCJN genes do not result in female-to-male sex reversal but in Cooks syndrome, a condition characterized by brachydactyly and anonychia (20) . A comprehensive overview of reported regulatory rearrangements of the SOX9 region are listed in Table 1 and depicted in Fig. 1 .
In an attempt to unravel the complex regulation of SOX9 expression, several studies searched for conserved non-coding elements (CNEs) that might act as tissue-specific enhancers (16, (21) (22) (23) (24) (Fig. 1) . Different tissue-specific enhancers have been identified (involved in neurodevelopment, chondrogenesis and craniofacial development); however the testis-specific SOX9 regulation remains enigmatic (25) . In general, SOX9 regulatory rearrangements that are associated with specific phenotypes cluster in four main regions, although there are no clear-cut genotype-phenotype correlations. The first and most upstream interval (−1230 to 1030 kb upstream of SOX9) is associated with PRS, the second (−932 to 601 kb upstream of SOX9) with milder forms of CD and acampomelic campomelic dysplasia (ACD) and the third (−375 to 50 kb upstream of SOX9) with more severe CD, respectively (Fig. 1) (27) (Fig. 1) .
Despite several efforts to identify gonadal-specific enhancers, the repositioning of which might cause sex reversal, no such elements have been found to date. In this respect, a particular duplication that causes 46,XX DSD is of special interest. Benko et al. identified a 148 kb duplication in a 46,XX ovotesticular DSD patient that was also present in the father and more surprisingly in the paternal, unaffected grandmother. It was hypothesized that changes in the regulatory region that harbors CNEs, could affect the chromatin state of the SOX9 promoter and more specifically of the testis-specific enhancer of SOX9 (TESCO) element, by alternative interactions between a specific regulatory element and TESCO. Chromatin profiling in fibroblasts showed that both the father and son had a more repressive signature in the region of the duplication and a more open chromatin state starting from the TESCO enhancer towards SOX9, compared with female controls, confirming this hypothesis. These epigenetic changes can be seen as a genetic background-based, superimposing regulatory element that can contribute to the observed incomplete penetrance (28) .
More insights into the pathogenic mechanisms underlying different classes of SOX9 regulatory duplications were recently provided by Franke et al. (29) by chromosome conformation capture studies (capture Hi-C and 4C-seq). As mentioned above, small regulatory duplications encompassing the RevSex region lead to 46,XX DSD, while larger duplications including this region but extending to the KCNJ genes cause Cooks syndrome. In addition, a third class of duplications was described, containing the RevSex region and the gene desert between the SOX9 and KCNJ genes but not the genes themselves. Duplications of this type do not lead to a specific phenotype (Fig. 1) . Franke et al. attribute these differential phenotypic expressions to different disruptions of topologically associated domains (TADs) (29) that represent Genomic build GRCh37/hg19 was used for all genomic coordinates. ACD, acampomelic dysplasia; CD, campomelic dysplasia; DSD, disorder of sex development; kb, kilobase; Mb, megabase; PRS, Pierre Robin sequence. a Duplication inherited from paternal grandmother, characterized by incomplete penetrance. therefore they are not shown in Fig. 1 . b The genomic coordinates for these rearrangements were not provided in the cited references, therefore they are not shown in Fig. 1 .
higher order chromatin structures in which interactions take place. They are separated from each other by boundaries, restricting the contacts that are established between enhancers and their target genes, and allowing intra-TAD but no inter-TAD interactions (30, 31) . The first class of duplications, leading to female-to-male sex reversal, affects a single TAD and are called intra-TAD duplications. The other two classes affect two neighboring TADs and their boundary (inter-TAD duplications). Intra-and inter-TADs have a different impact on chromatin organization, leading to a distinct phenotypic expression. The intra-TAD duplication does not alter the original TAD structure but leads to an increased number of interactions in the duplicated region itself and with SOX9, causing increased SOX9 activity and thus testis development in an XX individual. The inter-TAD duplications have an impact on chromatin structure and create an additional TAD (neo-TAD). The duplication found in the phenotypically normal family forms a neo-TAD that is isolated from the rest of the genome and that does not interact with the neighboring SOX9 and KCNJ genes, which are not included in the duplication. Duplications found in Cooks syndrome lead to a neo-TAD containing the KCNJ2 gene that has ectopic contacts with the duplicated SOX9 regulatory elements and that is misexpressed, hence resulting in a developmental limb phenotype. As SOX9 is located in another TAD in the latter situation, there is no sex developmental phenotype (29) . The concepts of this study will have impact on the interpretation of copy number variations that are found by routine genetic testing in DSD-related phenotypes.
SOX3
SOX regulatory rearrangements in DSD patients are not restricted to the SOX9 locus, but have also been described in the SOX3 region. Comparative sequence analysis and cytogenomic analyses led to the hypothesis that SRY arose from this gene (32) . Loss-of function mutations do not lead to sex determination defects, suggesting that SOX3 has no critical function in normal sex determination in humans. However, it was hypothesized that certain gain-of-function variants leading to ectopic SOX3 activation, could lead to female-to-male sex reversal. In 2011, Sutton et al. described three patients displaying 46,XX testicular DSD in which distinct SOX3 regulatory rearrangements were found (32) . In addition, a transgenic mouse model in which Sox3 is ectopically expressed in the developing XX gonads, is characterized by female-to-male sex reversal. These results show that gonadal SOX3 expression can act as a trigger for male sex development in the absence of SRY (32) . More recently an insertional translocation was reported in an individual with 46,XX ovotest/test DSD (33), which was shown to result in robust SOX3 expression in patient-derived lymphoblasts, while it was absent in XX and XY control individuals (33) .
DMRT1
Deletions of the short arm of chromosome 9 (9p) are associated with two distinct phenotypes. Telomeric deletions of 9p24.3 result in a genital phenotype ranging Fig. 1 . Schematic overview of 5 ′ regulatory defects of the SOX9 region. UCSC genome browser, build GRCh37/hg19. At the top, in black; conserved non-coding elements (CNEs) based on sequence homology between different species (16, (21) (22) (23) (24) . Identified inversions, deletions, duplications and translocations are depicted in orange, red, green and blue respectively. In general four regulatory intervals can be distinguished, shown in grey at the top of the picture (references in Table 1 ). The first interval, from 1030 to 1230 kb upstream of SOX9 is associated with Pierre Robin Sequence (PRS); the second (601-932 kb upstream of SOX9) is associated with acampomelic campomelic dysplasia (ACD) and isolated 46,XY Disorders of Sex Development (DSD); the third (50-375 kb upstream of SOX9) is associated with more severe campomelic dysplasia (CD). The RevSex region of 74 kb is the shortest region of overlap between the duplications identified in 46,XX DSD patients (24) . Recently, the RevSex region was even further refined to a 62 kb region (XXSR, pink vertical rectangle), at the same time a 46,XY DSD defining region was proposed (blue vertical rectangle) (26). Hyon et al. reduced the critical region for XX DSD to 41 kb (27) .
from isolated hypospadias to gonadal dysgenesis in XY individuals. More proximal interstitial deletions cause 9p-malformation syndrome, that is characterized by intellectual disability, congenital hypotonia and a spectrum of craniofacial abnormalities (34) . The region associated with sex development encompasses 1 Mb starting from the telomeric end and spanning the DMRT gene cluster. On the basis of its expression pattern, haploinsufficiency of DMRT1 was hypothesized to be the underlying mechanism (35, 36) . Only one telomeric 9p deletion that does not encompass the DMRT genes has been described in association with sex reversal (37, 38) . According to a previous study, the critical DMRT1 regulatory region reaches out to 6.5 kb upstream of the gene (39); however the deletion described by Calvari et al. has its breakpoint ∼40 kb upstream of DMRT1 (37, 38) . The authors hypothesize that the more distal location, in closer proximity to the telomere, could also affect DMRT1 expression despite the intact proximal regulatory region (38) . Moreover, it cannot be ruled out that this deletion affects additional more remote regulatory elements. However, a more complex mechanism in which DMRT1 dysregulation together with other effects would lead to gonadal dysgenesis, should also be considered. A combined dosage threshold effect could also explain the incomplete penetrance that was observed in several pedigrees (38) .
DAX1
The dosage sensitive Nuclear Receptor subfamily 0 group B member 1 (NR0B1, DAX1) gene is known to cause congenital adrenal hypoplasia (AHC) associated with hypogonadotropic hypogonadism when mutated or deleted, and 46,XY complete or partial gonadal (testicular) dysgenesis when duplicated (40, 41 (42) . In silico analysis of the deleted region identified several putative SF1-binding sites, evolutionarily conserved elements and cis-acting regulatory elements. The absence of adrenal insufficiency in this patient suggests that the deletion does not result in a loss-of-function effect. It was suggested that the deletion affects silencing cis-acting elements, thereby leading to increased activation of DAX1 and thus 46,XY sex reversal (42) . Other possible mechanisms such as the loss of an insulator or the juxtaposition of a long-range, gonadal ridge-specific enhancer cannot be excluded; however the net result should be increased DAX1 expression (42) . Interestingly, a large regulatory inversion, located about 4 kb upstream of DAX1, was identified in a patient with AHC (43). This inversion relocates an SF1-binding site that was previously associated with murine sex development. These findings represent another example of defects that, by affecting different regulatory elements, can cause distinct phenotypes, as was also illustrated for the SOX9 region (see above).
AR
Additional interesting regulatory mechanisms were added to the molecular pathogenesis of DSD, more specifically in the AR gene implicated in androgen insensitivity syndrome (AIS). First, a novel and recurrent 5 ′ untranslated region (5 ′ UTR) mutation was identified, confirming a 20-year-old hypothesis (44) . Indeed Mizokami and Chang had previously shown that certain regions of the AR 5 ′ UTR influence induction of translation without having an effect on transcription. It was hypothesized that mutations in this region might cause AIS, because they lead to a lower level of AR, without changing the transcript levels (45) . The identified variant introduces a new start codon to the AR 5 ′ UTR, and together with an in-frame stop codon 183 nucleotides downstream, this creates a short upstream open reading frame (uORF). The short alternative transcripts resulting from this can reduce translation levels of the downstream translated gene by inhibiting ribosome progression or by complicating the binding of pre-initiation complexes to the original translation start site (44) . Functional validation of this variant showed expression of a short polypeptide, reduced levels of normal AR protein, while the mRNA levels remain unchanged. Overall, this is a novel mechanism explaining the complete AIS phenotype in these patients (44) .
Very recently, Känsäkoski et al. identified a deep intronic AR variant (c.2450-118A>G) in two 46,XY sisters with complete AIS by whole-genome sequencing. This variant creates a de novo 5
′ splice site and a putative exonic splicing enhancer motif, leading to the preferential formation of two aberrantly spliced transcripts. The de novo 5 ′ splice site leads to the activation of a 3 ′ splice site 84 bp upstream of the variant. In ∼50% of the crypticly spliced transcripts a 202 nucleotide fragment downstream of the 3 ′ splice site is included. Both transcripts are predicted to cause a premature stop codon, predisposing them to nonsense mediated decay (NMD). Quantification of the normal AR transcript in patients' genital fibroblasts showed 10% levels compared with controls. Despite normal amounts of total AR mRNA, the AR protein was undetectable in patients' genital fibroblasts, suggesting that its stability is compromised, even if aberrant mRNA is translated (46) . This study shows the power of integrating whole-genome sequencing data with cDNA analyses to study deep intronic mutations in AIS patients. Previously, one other intronic mutation had been identified which had an impact on dihydrotestosterone binding, no effect on mRNA splicing was reported for this mutation (47) .
Taken together, the above studies emphasize the importance of non-coding AR mutations in the pathogenesis of AIS in case no coding AR mutation is found. (48) . This rearrangement manifests itself in sex reversal in XX mice. Histological analysis and in situ hybridization showed Sox9 expression in the sex reversed XX gonads. In silico analyses did not provide evidence for the involvement of a new sex development gene, but suggested that the phenotype was caused by altered regulation of Sox9 expression during embryogenesis either by affecting the surrounding chromatin structure or by rearrangement of tissue-specific, long-range, cis-acting enhancer/repressor elements (48) . However, two follow-up papers showed that the underlying mechanism was more complex and that perturbed Sox9 regulation alone was insufficient to cause the sex reversal phenotype (49, 50) . The first paper illustrates that the sex reversal phenotype is depending on the genetic background of the transgenic mouse, as crossing with an A/J strain resulted in normal female mice. Interestingly, a modifier locus on chromosome 18, Odsm, was found. Homozygosity for the allele from the original mouse strain strongly favors Ods sex reversal, while the A/J Odsm allele inhibits Ods sex reversal (49) . The second paper shows that upregulation of Sox9 was not solely depending on the removal of a potential regulatory element, but that it was provoked by the presence of the Dct promoter, which had a long-range activating effect (50) .
In dogs, XX DSD is quite a common phenotype, although no molecular causes were identified until recently. Rossi et al. were the first to identify SOX9 encompassing duplications in XX sex reversed dogs (51) . Given the fact that in humans both SOX9 encompassing and regulatory duplications are associated with 46,XX DSD, Marcinkowska-Swojak et al. explored the canine SOX9 regulatory region. Comparative sequence analysis revealed that the canine homologue (CanRevSex) of the human RevSex region (HumRevsex), which is located ∼0.5 Mb upstream of SOX9, can be found about 9 Mb downstream of SOX9. Customized high-resolution copy number screening revealed two highly variable regions CNVR1 and 2, respectively upstream and downstream of SOX9; however copy number variants (CNV) in these regions were detected in both affected dogs and in healthy controls. For CNVR1, an association between high copy numbers and XX DSD was noticed, suggesting the presence of another CNV or genetic variation in this region that is associated with the phenotype; no such association was observed for CNVs in CNVR2 however; although this is part of the CanRevSex region (52) . Recently, the assembly of the canine SOX9 regulatory region was revised, revealing that the CanRevSex region is also located upstream of SOX9. A new in silico analysis shows complete homology between the human and canine region (53) . The existence of this new assembly suggests that CNVs found in dogs should be reassessed to gain better understanding of their involvement in canine XX DSD.
FOXL2: regulatory defects in Polled Intersex goats and in piggyBac mice
A third regulatory animal model with sex reversal is the Polled Intersex (PIS) goat, characterized by dominant polledness and recessive XX sex reversal. Linkage analysis located the causal defect to chromosome band 1q43 (the orthologue of the 3q23 locus in humans) and via positional cloning the causal genetic defect was identified: a 11.7 kb deletion affecting the transcription of Pis-regulated transcript 1 (Pisrt1), a long non-coding RNA, and Forkhead box L2 (Foxl2) (54) . The exact mechanism behind the sex reversal phenotype was unclear at that time. Generation of homozygous Foxl2 knockout mice via zinc-finger nuclease mutagenesis proved that isolated loss of Foxl2 without affecting lncRNA expression is sufficient for developing the sex reversal phenotype in mice (55) . In humans, coding FOXL2 mutations and deletions have been described in blepharophimosis, ptosis, epicanthus inversus syndrome (BPES), a developmental eye condition associated (type I) or not (type II) with primary ovarian insufficiency (POI), and rarely associated with isolated POI (56) (57) (58) . Interestingly, several cis-acting regulatory deletions have been described in human cases with BPES (58) (59) (60) . It has been suggested that homozygous FOXL2 mutations might also result in 46,XX sex reversal, however no coding or regulatory mutations of FOXL2 have been found in 46,XX (ovo)testicular DSD cases to date (61, 62) .
A second Foxl2 associated regulatory animal model is the piggyBac (PB) mouse (63) . Insertional mutagenesis led to the identification of a mouse with a PB insertion approximately 160 kb upstream of Foxl2. This mutation leads to reduced Foxl2 expression and causes a phenotype reminiscent of BPES. Additional experiments showed interaction of the mutated region with the Foxl2 transcription start site in developing craniofacial tissues, showing that the piggyBac mouse is a good animal model to study Foxl2 regulation and the mechanisms underlying human BPES (63) .
Future perspectives and conclusions
The discoveries discussed in this review emphasize the importance of correct spatiotemporal gene expression during sex development and highlight an increasing number of non-coding defects in human and animal sex reversed phenotypes. While in most DSDs cases coding variants in known and yet to be discovered disease genes are to be expected, it is conceivable that at least part of the missing genetic variation can be explained by non-coding mutations in regulatory elements. A common action mechanism for such regulatory defects is removal or malpositioning of tissue-specific enhancer or silencer elements, leading to perturbed transcriptional activation and gene expression. Less frequent mechanisms, however, like uORFs in AR (44) and chromatin alterations in the SOX9 region (28) will evolve from future studies. Finally, the increasing number of non-coding defects in DSD illustrates that non-coding regions such as 5 ′ UTRs, intronic regions, proximal and distant cis-regulatory elements, mostly ignored in a routine context, should be examined in DSD patients with normal coding regions.
